Safety, Tolerability and PK of ATTO-3712 in Healthy Volunteers and Patients With Atopic Dermatitis

NCT07205081 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Normal Volunteers
Atopic Dermatitis (AD)
Atopic Eczema
Atopic Eczema/Dermatitis (Non-Specific)

Interventions

DRUG: ATTO-3712
DRUG: Placebo

Sponsor

Attovia Therapeutics Inc